[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Vistra Corp. Form 144 notice shows a proposed sale of 19,592 common shares with an aggregate market value of $3,933,635.66, scheduled for 09/10/2025 through Fidelity Brokerage Services LLC on the NYSE. The filing reports the securities were acquired by option grants dated 10/11/2016 (17,600 shares) and 04/06/2018 (1,992 shares), with payment recorded as cash on 09/10/2025. The registrant’s outstanding shares are listed as 338,820,324. The form states no securities were sold by the reporting person in the past three months. The filing lacks a populated issuer name and filer identification in the provided extract, which is not specified in the content.

Positive

• Sale scheduled through a major broker (Fidelity), indicating use of an established execution channel

Negative

• Extract lacks issuer name and filer identification, reducing traceability of the filing from the provided content

Insights

Securities Analyst

TL;DR: Routine Form 144: a small scheduled sale by option holders, executed through a major broker; limited market impact.

The notice documents a proposed sale of 19,592 common shares valued at $3.93 million to be executed on 09/10/2025 via Fidelity on the NYSE. Acquisition sources are option grants from 2016 and 2018, indicating these are vested option shares rather than recent purchases. The position represents a vanishingly small percentage of the listed 338.8 million outstanding shares, suggesting negligible dilution or market pressure. The filing is informational and follows Rule 144 protocols; it does not include the filer’s identifying CIK/CCC or a populated issuer name in the provided extract, which limits traceability.

Corporate Governance Expert

TL;DR: Disclosure is consistent with Rule 144 but missing some identifying details in the extract, reducing transparency.

The form indicates compliance with Rule 144 reporting for a planned sale via an institutional broker and discloses acquisition via option grants, dates, and cash payment. This level of detail about grant dates (10/11/2016 and 04/06/2018) supports review of insider grant timing and vesting. However, the absence of an explicitly populated issuer name and filer identifiers in the provided content is a governance shortfall in this extract and should be resolved to ensure clear public disclosure and traceability of insider transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	19592	3933635.66	338820324	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2025	Option Granted - 10/11/2016	Issuer			17600	09/10/2025	Cash
Common	09/10/2025	Option Granted - 04/06/2018	Issuer			1992	09/10/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does Vistra (VST) plan to sell according to this Form 144?

The notice lists a proposed sale of 19,592 common shares scheduled for 09/10/2025.

What is the aggregate market value and where will the sale be executed?

Aggregate market value is $3,933,635.66 and the sale is to be executed via Fidelity Brokerage Services LLC on the NYSE.

How were the shares acquired that are being sold on Form 144?

The shares were acquired via option grants dated 10/11/2016 (17,600 shares) and 04/06/2018 (1,992 shares).

Was payment for the acquired securities made in cash?

Yes; the filing records cash as the nature of payment on 09/10/2025.

Have any securities been sold by the reporting person in the past three months?

The form states "Nothing to Report" for securities sold during the past three months.

Are there any disclosure gaps in the provided Form 144 extract?

Yes; the provided extract does not populate the issuer name or filer identification fields, which limits traceability.